» Articles » PMID: 24362577

Chimeric Mice with Humanized Livers: a Unique Tool for in Vivo and in Vitro Enzyme Induction Studies

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2013 Dec 24
PMID 24362577
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

We performed in vivo and in vitro studies to determine the induction of human cytochrome P450 (CYP) using chimeric mice with humanized liver (PXB-mice®) and human hepatocytes isolated from the PXB-mice (PXB-cells), which were derived from the same donor. For the in vivo study, PXB-mice were injected with 3-methylcholanthrene (3-MC, 2 or 20 mg/kg) or rifampicin (0.1 or 10 mg/kg) for four days. For the in vitro study, PXB-cells were incubated with 3-MC (10, 50, or 250 ng/mL) or with rifampicin (5 or 25 μg/mL). The CYP1A1 and 1A2, and CYP3A4 mRNA expression levels increased significantly in the PXB-mouse livers with 20 mg/kg of 3-MC (Cmax, 12.2 ng/mL), and 10 mg/kg rifampicin (Cmax, 6.9 µg/mL), respectively. The CYP1A1 mRNA expression level increased significantly in PXB-cells with 250 ng/mL of 3-MC, indicating lower sensitivity than in vivo. The CYP1A2 and CYP3A4 mRNA expression levels increased significantly with 50 ng/mL of 3-MC, and 5 μg/mL of rifampicin, respectively, which indicated that the sensitivities were similar between in vivo and in vitro studies. In conclusion, PXB-mice and PXB-cells provide a robust model as an intermediate between in vivo and in vitro human metabolic enzyme induction studies.

Citing Articles

Investigation of Biotransformation Pathways in a Chimeric Mouse with a Humanized Liver.

Karlsson I, Ekdahl A, Etchingham-Coll H, Li X, Ericsson C, Ahlqvist M Int J Mol Sci. 2025; 26(3).

PMID: 39940909 PMC: 11818726. DOI: 10.3390/ijms26031141.


Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration.

Shishido Y, Yoshida T, Oshida K, Uchida M Pharmacol Res Perspect. 2024; 12(5):e70017.

PMID: 39312270 PMC: 11418634. DOI: 10.1002/prp2.70017.


Nanoprojectile Secondary Ion Mass Spectrometry Enables Multiplexed Analysis of Individual Hepatic Extracellular Vesicles.

Lee S, Verkhoturov D, Eller M, Verkhoturov S, Shaw M, Gwon K ACS Nano. 2023; 17(23):23584-23594.

PMID: 38033295 PMC: 10985841. DOI: 10.1021/acsnano.3c06604.


Adipose Tissue-Derived Mesenchymal Stem Cells Extend the Lifespan and Enhance Liver Function in Hepatocyte Organoids.

Ock S, Kim S, Ju W, Kim Y, Wi H, Lee P Int J Mol Sci. 2023; 24(20).

PMID: 37895114 PMC: 10607770. DOI: 10.3390/ijms242015429.


Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion.

Arakawa H, Nakazono Y, Matsuoka N, Hayashi M, Shirasaka Y, Hirao A Commun Biol. 2023; 6(1):866.

PMID: 37608051 PMC: 10444810. DOI: 10.1038/s42003-023-05216-z.


References
1.
Okumura H, Katoh M, Sawada T, Nakajima M, Soeno Y, Yabuuchi H . Humanization of excretory pathway in chimeric mice with humanized liver. Toxicol Sci. 2007; 97(2):533-8. DOI: 10.1093/toxsci/kfm041. View

2.
Asahina K, Sato H, Yamasaki C, Kataoka M, Shiokawa M, Katayama S . Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver. Am J Pathol. 2002; 160(6):2191-205. PMC: 1850835. DOI: 10.1016/S0002-9440(10)61167-4. View

3.
Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E . Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol. 2007; 25(8):903-10. PMC: 3404624. DOI: 10.1038/nbt1326. View

4.
Polk R, Brophy D, Israel D, Patron R, Sadler B, Chittick G . Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males. Antimicrob Agents Chemother. 2001; 45(2):502-8. PMC: 90319. DOI: 10.1128/AAC.45.2.502-508.2001. View

5.
Thissen J, Pucilowska J, Underwood L . Differential regulation of insulin-like growth factor I (IGF-I) and IGF binding protein-1 messenger ribonucleic acids by amino acid availability and growth hormone in rat hepatocyte primary culture. Endocrinology. 1994; 134(3):1570-6. DOI: 10.1210/endo.134.3.7509741. View